Foto del docente

Michele Fusaroli

Dottorando

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIO/14 FARMACOLOGIA

Pubblicazioni

Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E., Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS, «DRUG SAFETY», 2024, 47, pp. 271 - 284 [articolo]Open Access

Pauline O.; Robert M.; Bernardeau C.; Hlavaty A.; Fusaroli M.; Roustit M.; Cracowski J.L.; Khouri C., Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database, «BIODRUGS», 2023, 37, pp. 699 - 707 [articolo]

Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E., Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct, «ADDICTION», 2023, 118, pp. 763 - 770 [articolo]Open Access

Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco, Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors, «JTO CLINICAL AND RESEARCH REPORTS», 2023, 4, Article number: 100563, pp. 1 - 8 [articolo]

Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, Rita; Potena, Luciano, Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians, «DRUG SAFETY», 2023, 46, pp. 819 - 833 [articolo]Open Access

Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta, Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach, «DRUG SAFETY», 2023, 46, pp. 921 - 926 [articolo]

Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E., Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, «DRUG SAFETY», 2023, 46, pp. 283 - 295 [articolo]Open Access

Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E., Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, «PSYCHIATRY AND CLINICAL NEUROSCIENCES», 2023, 77, pp. 160 - 167 [articolo]Open Access

Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R., Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System, «JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH», 2023, 66, pp. 3242 - 3259 [articolo]

Khouri, Charles; Fusaroli, Michele; Salvo, Francesco; Raschi, Emanuel, Interpretation of Pharmacovigilance Disproportionality Analyses, «CLINICAL PHARMACOLOGY & THERAPEUTICS», 2023, 114, pp. 745 - 746 [replica/breve intervento]

Fusaroli M.; Salvo F.; Bernardeau C.; Idris M.; Dolladille C.; Pariente A.; Poluzzi E.; Raschi E.; Khouri C., Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study, «DRUG SAFETY», 2023, 46, pp. 857 - 866 [articolo]

Giunchi V.; Fusaroli M.; Linder E.; Villén J.; Wettermark B.; Nekoro M.; Raschi E.; Lunghi C.; Poluzzi E., The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 2020 - 2027 [articolo]Open Access

Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G., Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System, «CANCERS», 2022, 14, Article number: 4610, pp. 1 - 13 [articolo]Open Access

Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J.; Poluzzi E., Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System, «DRUG SAFETY», 2022, 45, pp. 663 - 673 [articolo]

Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F., Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems, «JN. JOURNAL OF NEPHROLOGY», 2022, 35, pp. 1017 - 1027 [articolo]Open Access

Ultimi avvisi

Al momento non sono presenti avvisi.